SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-23-010945 from Enliven Therapeutics, Inc. (ELVN) (CIK 0001672619) (ELVN)

Enliven Therapeutics, Inc. (ELVN) (CIK 0001672619)
Date: Jan. 19, 2023 · CIK: 0001672619 · Accession: 0001193125-23-010945

AI Filing Summary & Sentiment

File numbers found in text: 333-268300

Date
January 19, 2023
Author
Not clearly detected
Form
CORRESP
Company
Enliven Therapeutics, Inc. (ELVN) (CIK 0001672619)

Letter

Imara Inc.

1309 Beacon Street, Suite 300, Office 341

Brookline, MA 02446

January 19, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jenn Do

Kevin Vaughn

Lauren Hamill

Tim Buchmiller

Re: Imara Inc.

Registration Statement on Form S-4

File No. 333-268300

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Imara Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-4 (File No. 333-268300), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on January 23, 2023, or as soon thereafter as practicable.

Very truly yours,
IMARA INC.

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

 Imara Inc.

1309 Beacon Street, Suite 300, Office 341

 Brookline, MA 02446

 January 19, 2023

 VIA EDGAR

Securities and Exchange Commission

 Division of Corporation
Finance

 100 F Street, N.E.

 Washington, D.C. 20549

Attention:           Jenn Do

Kevin Vaughn

 Lauren Hamill

 Tim Buchmiller

Re:
 Imara Inc.

Registration Statement on Form S-4

File No. 333-268300

Request for Acceleration

 Ladies and
Gentlemen:

 Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Imara Inc. (the “Registrant”) hereby requests
acceleration of the effective date of its Registration Statement on Form S-4 (File No. 333-268300), as amended (the “Registration Statement”), so that it
may become effective at 4:00 p.m. Eastern time on January 23, 2023, or as soon thereafter as practicable.

Very truly yours,

IMARA INC.

By:

 /s/ Rahul D. Ballal, Ph.D.

Name:

Rahul D. Ballal, Ph.D.

Title:

President and Chief Executive Officer